Searchable abstracts of presentations at key conferences in endocrinology

ea0081p139 | Pituitary and Neuroendocrinology | ECE2022

Pituitary apoplexy in the aftermath of a SARS-CoV-2 infection: a case series from Amiens University Hospital

Balmain Joe , Al-Salameh Abdallah , Desailloud Rachel

Introduction: Since the outbreak of the COVID-19 pandemic, several cases of pituitary apoplexy following a SARS-CoV-2 infection have been described in several countries. Here, we describe a case series of pituitary apoplexy occurring in the aftermath of a SARS-CoV-2 infection to alert physicians about possible neuro-endocrinological damage caused by the virus that can lead to visual sequelae and hypopituitarism.Methods: We retrospectively identified all ...

ea0022p772 | Thyroid | ECE2010

Vitamin D deficiency contributes to post-thyroidectomy hypocalcemia

Jacques Aurelie , Page Cyril , Justinien Etienne , Strunski Vladimir , Desailloud Rachel

Hypocalcemia is a classic complication after total thyroidectomy, mostly due to post-operative hypoparathyroidism. However others factors, like vitamin D deficiency, may contribute to this hypocalcemia.Objective: To determine if vitamin D preoperative status influence early postoperative serum calcium levels after total thyroidectomy.Patients and methods: Seventy-nine patients (65 women/14 men), mean age 52.8 (±12.7), were inc...

ea0081rc7.4 | Rapid Communications 7: Pituitary and Neuroendocrinology 2 | ECE2022

Evaluation of the impact of covid-19 on the hypothalamic-pituitary-adrenal axis and the hypothalamic-pituitary-thyroid axis

Andre Juliette , Al-Salameh Abdallah , Scherman Noemie , Andrejak Claire , Desailloud Rachel

Context: The long-term consequences of Covid-19 are unknown. Most patients experience persistent symptoms more than a month after the acute illness, including fatigue, dyspnea, memory loss, concentration disorder. The pituitary, the thyroid and the adrenal gland express the ACE-2 receptor, which is the cellular receptor for SARS-CoV-2, and could therefore be affected by the virus. However, the effect of Covid-19 on the hypothalamic-pituitary-adrenal-axis and hypothalamic-pitui...

ea0035p1037 | Thyroid (non-cancer) | ECE2014

Grave's disease as an adverse effect of ipilimumab: first description of two cases

Coppin Mathilde , Arnault Jean-Philippe , Lameth Ileana De , Flahaut Helene , Desailloud Rachel

Ipilimumab is an immunomodulating agent for the treatment of metastatic melanoma. Ipilimumab is a human mAb which works by inhibiting cytotoxic T-lymphocyte antigen 4 (CTLA-4).CTLA4 typically works to down-regulate the T-cell response and protects self-antigens from recognition by the immune system. Since the T-cells are no longer down-regulated by this antigen, they are allowed to proliferate, thereby helping to prevent melanoma tumor evasion. As a resu...

ea0022p795 | Thyroid | ECE2010

Parvovirus B19 infection: a possible role in autoimmune thyroid diseases

Justinien Etienne , Pannier Christine , Page Cyril , Segard Christine , Strunski Vladimir , Sevestre Henri , Duverlie Gilles , Desailloud Rachel

Introduction: Autoimmune thyroid disease (AITD) is a common disease. It arise due to interactions between genetic background and environmental factors. However this interactions remain unclear. As it induces other autoimmune diseases, parvovirus is an attractive candidate.Objective: To investigate the presence of parvoviral DNA in postoperative thyroid tissues.Materials and methods: We collect prospectively postoperative thyroid sp...

ea0073pep13.2 | Presented ePosters 13: Pituitary and Neuroendocrinology | ECE2021

Use of free triiodothyronine level in central hypothyroidism management

Bouzegaoui Nacera El , Ornella Raad , Marion Soyez , Abdallah Al Salameh , Rachel Desailloud

IntroductionThere is no consensus about biological targets in patients with central hypothyroidism (CH). The main objective of this work was to characterize our patients with CH.DesignWe conducted a retrospective study at the University Hospital of Amiens. In our center, patients with CH are considered “well substituted” if the free thyroxine (FT4) is in the upper half of the reference interval and ...

ea0037gp.10.10 | Calcium, Vitamin D and Bone | ECE2015

Phenotype–genotype correlation in a series of 131 patients studied for calcium-sensing receptor gene

Vahe Claire , Odou Marie-Francoise , Desailloud Rachel , Leroy Clara , Bauters Catherine , Scherpereel Arnaud , Pattou Francois , Carnaille Bruno , Wemeau Jean-Louis , Vantyghem Marie-Christine

Calcium-sensing receptor gene (CASR) loss-of-function mutations lead to familial hypocalciuric hypercalcaemia (FHH), neonatal severe hyperparathyroidism, and primary hyperparathyroidism. FFH is characterized by mild hypercalcaemia, hypocalciuria, calcium clearance/creatinine clearance (CaCl/CrCl) <0.01, normal or high PTH level. Nevertheless the phenotype may vary (Thakker 2012). The aim of this work was to compare the phenotypes of patients bearing or not a pathogenic <em...

ea0081oc2.3 | Oral Communications 2: Adrenal and Cardiovascular Endocrinology 1 | ECE2022

Loss of lysine demethylase KDM1A in GIP-dependent bilateral macronodular adrenal hyperplasia with Cushing’s syndrome

Chasseloup Fanny , Bourdeau Isabelle , Tabarin Antoine , Regazzo Daniela , Dumontet Charles , Ladurelle Nataly , Tosca Lucie , Amazit Larbi , Proust Alexis , Scharfmann Raphael , Fiore Frederic , Tsagarakis Stylianos , Vassiliadi Dimitra , Maiter Dominique , Young Jacques , Lecoq Anne-Lise , Demeocq Vianney , Salenave Sylvie , Lefebvre Herve , Cloix Lucie , Emy Philippe , Desailloud Rachel , Vezzosi Delphine , Scaroni Carla , Barbot Mattia , de Herder Wouter , Pattou Francois , Tetreault Martine , Corbeil Gilles , Dupeux Margot , Lambert Benoit , Tachdjian Gerard , Guiochon-Mantel Anne , Beau Isabelle , Chanson Philippe , Viengchareun Say , Lacroix Andre , Bouligand Jerome , Kamenicky Peter

Context: Primary bilateral macronodular adrenal hyperplasia (PBMAH) with glucose-dependent insulinotropic polypeptide (GIP)-dependent Cushing’s syndrome is caused by ectopic expression of GIP receptor in the adrenal tissue. The bilateral nature of this adrenal disease suggests germline genetic predisposition. We aimed to identify the molecular driver event responsible for ectopic GIP receptor expression in PBMAH.Methods: We conducted an internationa...

ea0063oc5.1 | Adrenal 1 | ECE2019

Positive impact of genetic test on the management and outcome of patients with paraganglioma and/or pheochromocytoma

Buffet Alexandre , Aim Laurene Ben , Leboulleux Sophie , Drui Delphine , Vezzosi Delphine , Libe Rossella , Ajzenberg Christiane , Bernardeschi Daniele , Cariou Bertrand , Chabolle Frederic , Chabre Olivier , Darrouzet Vincent , Delemer Brigitte , Desailloud Rachel , Goichot Bernard , Esvant Annabelle , Offredo Lucile , Herman Philippe , Laboureau Sandrine , Lefebvre Herve , Pierre Peggy , Raingeard Isabelle , Reznik Yves , Sadoul Jean-Louis , Hadoux Julien , Tabarin Antoine , Tauveron Igor , Zenaty Delphine , Favier Judith , Bertherat Jerome , Baudin Eric , Amar Laurence , Gimenez-Roqueplo Anne-Paule

Context: Paragangliomas and pheochromocytomas (PPGL) are rare neuroendocrine tumors, characterized by a strong genetic component. Indeed, up to 40% of patients carry a germline mutation in a PPGL susceptibility gene. In accordance with the international recommendations, genotyping of PPGL susceptibility genes is therefore proposed to all patients with PPGL, but it has actually never been shown whether the identification of a germline mutation in one PPGL susceptibility gene ch...